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Abstract
Introduction: We present the case of a patient with a cobalamin deficiency resulting in
pancytopaenia, emphasizing the importance to define, diagnose and treat cobalamin deficiency.
Case presentation: A 52-year-old man from the Democratic Republic of Congo presented to
the emergency department with shortness of breath and a sore tongue. Physical examination was
unremarkable. His haemoglobin was low and the peripheral blood smear revealed pancytopaenia
with a thrombotic microangiopathy. The findings were low cobalamin and folate levels, and high
homocysteine and methylmalonate levels. Pernicious anaemia with chronic atrophic gastritis was
confirmed by gastric biopsy and positive antiparietal cell and anti-intrinsic factor antibodies.
Cobalamin with added folate was given. Six months later, the patient was asymptomatic.
Conclusion: Cobalamin deficiency should always be ruled out in a patient with pancytopaenia. Our
case report highlights a life-threatening cobalamin deficiency completely reversible after treatment.
Introduction
Pernicious anaemia is a common cause of cobalamin defi-
ciency, as discussed by Biermer in 1872. Whipple, Minot
and Murphy developed a treatment with a liver extract in
the late 1920s, suggesting an association between an
extrinsic factor found in the liver and an intrinsic factor in
the gastric juice. Folkers et al. isolated the extrinsic factor,
that is, cobalamin, in the late 1940s. In the 1950s, Hodg-
kin et al. used X-ray crystallography to reveal the structure
of cobalamin. Nevertheless, there is still no gold standard
for diagnosis, and nor are there clear guidelines for the
treatment of cobalamin deficiency [1,2].
A population survey in the United States revealed that
1.9% of people older than 60 years of age have undiag-
nosed pernicious anaemia. The introduction of folate for-
tification in the United States has left some of the
population at risk for a masked cobalamin deficiency [3].
Case presentation
A 52-year-old man from the Democratic Republic of
Congo presented to the emergency department after 14
days of shortness of breath, general weakness, weight loss
and a sore tongue. He had no cough, chest pain or fever,
and there was nothing significant in his medical and fam-
ily history. He did not smoke nor drink alcohol. On exam-
ination, he appeared uncomfortable, anicteric and
afebrile with a respiratory rate of 28 per minute, regular
pulse of 70 beats per minute and blood pressure of 111/
76 mmHg. A cardiovascular examination showed normal
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patient's tongue was unremarkable, as were the abdomi-
nal and neurologic examinations.
A chest X-ray and a full blood count were then ordered.
The patient's chest X-ray was normal. His full blood count
examination showed pancytopaenia. His hematocrit was
21% with a mean corpuscular volume of 107 fl and an
absolute reticulocyte count of 31,000/mm3. His white
blood cell count was 3600/mm3 with 27% neutrophils,
63% lymphocytes and 96,000/mm3 platelets. A peripheral
blood smear (Figure 1) revealed anisocytosis and hyper-
segmented neutrophils. Other findings were low levels of
cobalamin (52 pmol/l; normal range: 133-675), folate
(4.2 nmol/l; normal value: >6.8), and haptoglobin (<0.1
g/l; normal range: 0.3-2), and high levels of lactate dehy-
drogenase (LDH) (4604 U/l; normal range: 135-225),
homocysteine (Hcys) (101 μmol/l; normal range: 5-15),
and methylmalonate (MMA) (1.12 μmol/l; normal value:
<0.28). The level of the patient's creatinine (83 μmol/l;
normal range: 62-106) and potassium (4.4 mmol/l; nor-
mal range: 3.6-4.4) were normal, as were the other find-
ings. A gastroscopy showed oedematous gastric mucosa
and a biopsy showed atrophic gastritis (Figure 2). Anti-
parietal cell and anti-intrinsic factor antibodies were pos-
itive.
The patient was given two units of packed red cells, which
improved his respiratory symptoms. Cobalamin (1000 μg
intramuscularly) was given daily for 7 days, then weekly
for 4 weeks, and then prescribed at a maintenance dose of
1000 μg once a month for life [4]. Daily folate of 5 mg
orally was also given for 3 months. The patient was not
admitted and follow-up was arranged in our ambulatory
setting.
Nine days after introduction of therapy, correction of his
deficiencies led to marked reticulocytosis (200,000/
mm3). Six months later, the patient was asymptomatic
and the peripheral blood smear was normal. His levels of
cobalamin (505 pmol/l), folate (9.6 nmol/l; >5.3), MMA
(0.26 μmol/l; <0.28), and Hcys (9.8 μmol/l; 5-15) were
also normal.
Discussion
Cobalamin deficiency was our leading diagnosis; other
causes of pancytopenia including dysthyroidism, HIV,
Epstein-Barr virus, cytomegalovirus, herpes simplex virus,
hepatitis B virus and hepatitis C virus infection were ruled
out afterwards. Myeloproliferative disorders were less
likely, and for this reason, a bone marrow aspiration was
not performed. Pulmonary tuberculosis was not suggested
given the absence of history and a normal chest X-ray. The
Peripheral blood smear (May-Grünwald Giemsa stain), 500×Figur  1
Peripheral blood smear (May-Grünwald Giemsa 
stain), 500×. Macro-ovalocytes. Schistocytes (arrows).
Gastric (body) biopsy (haematoxylin and eosin), 40×Figu e 2
Gastric (body) biopsy (haematoxylin and eosin), 40×. 
Intestinal metaplasia with goblets cells. The lamina propria is 
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(page number not for citation purposes)
Journal of Medical Case Reports 2009, 3:80 http://www.jmedicalcasereports.com/content/3/1/80dramatic response to therapy precluded any necessity for
further investigations.
Most patients with cobalamin deficiency exhibit signs of
peripheral nervous system or spinal cord involvement [5].
Our patient developed a non-neurologic manifestation - a
sore tongue that was proven reversible after treatment.
Severe life-threatening haematologic findings such as pan-
cytopaenia, thrombotic microangiopathy and haemolytic
anaemia (high LDH, low haptoglobin, schistocytes and
thrombopaenia) due to cobalamin deficiency were
observed in our patient. These findings are rare and were
Diagnostic and therapeutic approach for cobalamin deficiency [2,4]Figure 3
Diagnostic and therapeutic approach for cobalamin deficiency [2,4]. Cbl (cobalamin), MMA (methylmalonate), Hcys 
(homocysteine), holoTC (holotranscobalaminII), PA (pernicious anaemia), n. (normal) *No clear consensus among authors to 
identify the grey zone (150-250 pmol/L).
 People at risk of cbl deficiency or with clinical symptoms of cbl 
Clinic deficiency (elderly, gastric surgery, chronic gastritis, chronic alcoholism, 
 chronic ingestion of antacids, veganism, or HIV) 
Biological tests Measure cbl and check creatinine (to rule out a renal failure) 
Cbl (pmol/L) >220 (250∗) 150-220 (250∗) <150 
Diagnostics  
  
n. MMA     n.holoTC 
n. Hcys      n. Hcys 
 MMA              holoTC 
   Hcys             Hcys 
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French study of severe haematological conditions result-
ing from cobalamin deficiency [5]. There are also case
reports involving severe cobalamin deficiency that mim-
icked leukaemia or thrombotic microangiopathy [6-8].
The prevalence of cobalamin deficiency is notable, espe-
cially among older individuals (14%) [9]. General popu-
lation studies show a prevalence of cobalamin deficiency
of around 20% in Western countries [4]. Until recently, it
was believed that pernicious anaemia involved mainly
Caucasians, but previous studies provide evidence that
pernicious anaemia is as common in Africans also [10].
The most common causes of cobalamin deficiency are
food-cobalamin malabsorption and pernicious anaemia,
mainly among older people. Other causes include dietary
deficiency, malabsorption and hereditary metabolic dis-
ease [5]. Patients at risk for cobalamin deficiency include
those who have had gastric surgery or a history of chronic
gastritis, chronic alcoholism, chronic ingestion of antac-
ids, veganism or HIV [4].
Diagnosing cobalamin deficiency is straightforward when
the deficiency is profound. Nevertheless, diagnosing a
slight deficiency is more difficult in older patients and in
patients with neurological symptoms who present a bor-
derline cobalamin level. Classically, the diagnosis is based
on a low cobalamin level, but elevated MMA and Hcys
levels seem more sensitive and more specific [11]. Renal
failure may also increase MMA and Hcys levels and high
Hcys level may also reveal a folate deficiency [11].
Solomon evaluated patients for cobalamin deficiency
using the standard metabolic markers MMA and Hcys in a
retrospective study of the records of patients in an ambu-
latory setting over a 10-year period [12]. The levels of the
three metabolic markers were measured before any treat-
ment was given. Cobalamin, MMA, Hcys levels showed a
wide variability over time, and taken individually or in
combination did not predict or rule out a haematological
or neurological response to cobalamin therapy [12].
There are also new methods available to diagnose cobala-
min deficiency. In plasma, total plasma cobalamin is
bound to two proteins, haptocorrin and transcobalamin.
Normally, 80% of cobalamin is on plasma haptocorrin
and forms a holohaptocorrin. About 20% of cobalamin is
combined with transcobalamin II to form the biologically
active fraction holotranscobalamin II (holoTC), which is
available for cell use. HoloTC levels seem to be an early
indicator of cobalamin deficiency [13]. Several studies
showed that holoTC might be a promising first-line test or
used in combination with a metabolic marker (MMA or
Hcys) for diagnosing cobalamin deficiency [2,13]. In
patients at risk or with clinical symptoms, we suggest a
comprehensive care approach (Figure 3) [2,4].
Anti-intrinsic factors are more specific than antiparietal
cell antibodies and are found in the serum of almost 40%
of patients [14]. Both factors were positive in our patient.
A gastric biopsy showed a marked lymphocyte infiltrate in
the lamina propria, and the mucosa revealed intestinal
metaplasia with goblet cells (Figure 2). The standard treat-
ment of cobalamin deficiency is intramuscular, but oral
supplementation has shown an efficacy equal to injection
for pernicious anaemia and other cobalamin deficiencies
[15]. Life-long cobalamin substitution is necessary in per-
nicious anaemia [4].
Conclusion
We present an unusual case of cobalamin deficiency
resulting in severe pancytopaenia with thrombotic micro-
angiopathy that was completely reversible after cobala-
min substitution. Primary care physicians must be aware
of patients at risk for cobalamin deficiencies irrespective
of the ethnic origin of the patient. No single algorithm fits
every patient, and there is no clear consensus on how to
diagnose and treat cobalamin deficiency. Consequently,
the diagnosis should rely on clinical epidemiology, clini-
cal symptoms and biochemical markers.
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